2022 ESMO ｜ Professor Wu Zhongsheng: Good safety, better liver safety, Darcille may become HR+/HER2-advanced breast cancer first-line treatment preferred
*For medical professionals for reading referenceDAWNA-2 research mid-term analysis...
New idea of prostate cancer treatment: use Protac to lower therogens receptor!
New idea of prostate cancer treatment: use Protac to lower therogens receptor!...
The first half of the drug revenue of 1.78 million operating funds depended on external financing, etc.
On the evening of August 15th, the first medicine holding (SH688197, a stock price...
Ding Ding Pharmaceuticals to stop bleeding, some varieties are suspended
Ding Ding Pharmaceutical has entered a critical turning period.On August 10th, Din...
Domestic innovation medicine evidence -based "milestone"!Zibutoni related studies were published in high scores of "Liuye Knife · Oncology"!
Recently, the BTK inhibitors independently developed by Baiji Divine Divine Phase III Sequoia study mid -term analysis data was published in the top international journal The Lancet Oncology magazin
Strive for cancer towards the "era of slow disease management" nuclear medical technology new breakthrough "Prague therapy" shiny worldwide
On July 8th, the Prague Treatment version 1.0 research results created by Professor Zhang Liyuan, a Nuclear Industry General Hospital (Suzhou University Affiliated Hospital). Frontiers in Immunology
Why are the two -metal dual -dual -double used, and the other two types of hypoglycemic drugs are used more and more?
A friend with diabetes told Huazi that he found that there were fewer and fewer pe...
Professor Shen Yang's new achievements of ovarian cancer treatment of ovarian cancer was published in the world -renowned journal
Recently, Professor Shen Yang, deputy dean of the University of Southeast Universi...